Companies: 10,795·Total market cap: $144.5T

Panacea Life Sciences Holdings, Inc.

Panacea Life Sciences Holdings, Inc.

PLSHOTCHealthcare● Active

$0.03

+$0.00(+0.00%)

Market Cap$679161

P/E Ratio—

52W High$0.1996

52W Low$0.0211

Avg Volume16K

Open$0.03

Beta2.68

Net Income Financials Revenue

Panacea Life Sciences Holdings, Inc. (PLSH) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PLSH · net income · updated Jun 15, 2026

Core profitability metrics

PLSH · net income · margin · TTM · CAGR

Net income was −$416,675 for FY2025 (fiscal year ending 2025-12-31), up 28.6% year-over-year. Net profit margin was -45.8%.

FY2025 Net Income−$416,675▲ +28.6% YoY

Trailing 12M (TTM)−$4.0Mtrailing 4 quarters sum

Net Profit Margin-45.8%−$416,675 ÷ $910,518

YoY Change+28.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · PLSH net income history · PLSH profit margin

Annual net income data

PLSH · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$416,675▲ +28.6%-45.8%$910,518

FY2024Loss−$583,200▲ +92.7%-14.2%$4.1M

FY2023Loss−$8.0M▲ +27.8%-336.1%$2.4M

FY2022Loss−$11.1M▼ 81.2%-682.1%$1.6M

FY2021Loss−$6.1M▲ +12.4%-297.4%$2.1M

Net income vs peers (Healthcare)

PLSH vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Panacea Life Sciences Holdings, Inc.YOU

PLSH

−$416,675+28.6%-45.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Panacea Life Sciences Holdings, Inc. (PLSH) reported net income of −$416,675 for FY2025 (fiscal year ending 2025-12-31), up 28.6% year-over-year. The net profit margin was -45.8% — meaning the company kept $-0.46 of every dollar of revenue as profit.

Panacea Life Sciences Holdings, Inc. has not yet achieved annual profitability based on available data (11 fiscal years). The company has reported net losses across all available periods.

Panacea Life Sciences Holdings, Inc.'s net profit margin was -45.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Panacea Life Sciences Holdings, Inc. net worth" — the company's market capitalization is a separate figure from PLSH net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

PLSH net income · 4 questions

Panacea Life Sciences Holdings, Inc. is not currently profitable on an annual basis. The company reported a net loss of $416,675 for FY2025.

is PLSH profitabledoes PLSH make a profitPLSH profitabilityPLSH profitable company

▸ Source: FMP /income-statement · GAAP · Panacea Life Sciences Holdings, Inc. · Panacea Life Sciences Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026